Andere talen Omnicell, Inc.

Aandelen

Vertraagde tijd Nasdaq Andere beurzen 21:48:45 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
28,32 ^USD	+0,48%		+6,27%	-24,74%

16/04	Omnicell, Inc. Kondigt XT Amplify aan	CI
29/02	Omnicell, Inc. Kondigt veranderingen in leiding aan	CI

Omnicell Announces XT Amplify	16/04
Omnicell, Inc. Announces XT Amplify	16/04
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024	08/04
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum	11/03
Omnicell, Inc. Announces Executive Changes	29/02
Omnicell Fiscal Q4 Non-GAAP Net Income Flat, Revenue Falls; Sets Outlook	08/02
Omnicell: Q4 Earnings Snapshot	08/02
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results	08/02
(OMCL) OMNICELL Sees Q1 Revenue Range $232M - $242M	08/02
(OMCL) OMNICELL Expects Fiscal Year 2024 EPS Range $0.90 - $1.40	08/02
Earnings Flash (OMCL) OMNICELL Reports Q4 Revenue $258.8M, vs. Street Est of $255.6M	08/02
Omnicell, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year 2024	08/02
Earnings Flash (OMCL) OMNICELL Posts Q4 EPS $0.33, vs. Street Est of $0.15	08/02
Omnicell, Inc. Reports Unaudited Impairment Changes Results for the Fourth Quarter Ended December 31, 2023	08/02
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024	16/01
Omnicell Elects Eileen Voynick to Board of Directors	11/01
Omnicell, Inc. Announces Board Changes	11/01
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference	27/11
North American Morning Briefing : Stocks Look to -2-	06/11

Geen resultaten voor deze zoekopdracht